Vocara® (Drops) Instructions for Use
Marketing Authorization Holder
Richard Bittner, AG (Austria)
ATC Code
R02AA20 (Other antiseptics)
Dosage Form
| Vocara® | Homeopathic drops 20 ml, 50 ml, or 100 ml: dropper bottles |
Dosage Form, Packaging, and Composition
Homeopathic drops in the form of a clear liquid with a yellowish tint and a specific odor.
| 100 ml | |
| Sage (Salvia) D1 | 7 ml |
| Belladonna (Belladonna) D6 | 10 ml |
| Pokeweed (Phytolacca) D6 | 10 ml |
| Bushmaster snake venom (Lachesis) D12 | 10 ml |
| Mercurius solubilis Hahnemanni (Mercurius solubilis Hahnemanni) D12 | 10 ml |
Excipients: ethanol 43% by weight.
20 ml – dark glass dropper bottle (1) – cardboard boxes.
50 ml – dark glass dropper bottle (1) – cardboard boxes.
100 ml – dark glass dropper bottle (1) – cardboard boxes.
Clinical-Pharmacological Group
Homeopathic preparation used for diseases of the oral cavity and pharynx
Pharmacotherapeutic Group
Homeopathic agent
Pharmacological Action
A complex homeopathic preparation, the action of which is determined by the properties of the components included in its composition.
It has anti-inflammatory, antimicrobial, immunostimulating, and detoxifying effects.
Pharmacokinetics
The action of the drug Vocara® is the result of the combined action of its components; therefore, conducting kinetic observations is not possible.
All components together cannot be traced using markers or bioassays.
For the same reason, it is impossible to detect the drug’s metabolites.
Indications
As part of the complex therapy of diseases of the oral cavity and pharynx, including:
- Tonsillitis;
- Pharyngitis;
- Lymphadenitis;
- Stomatitis;
- Gingivitis.
ICD codes
| ICD-10 code | Indication |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J31 | Chronic rhinitis, nasopharyngitis and pharyngitis |
| J35.0 | Chronic tonsillitis |
| K05 | Gingivitis and periodontal diseases |
| K12 | Stomatitis and related lesions |
| ICD-11 code | Indication |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA09 | Chronic rhinitis, nasopharyngitis or pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Adults and adolescents over 12 years of age are prescribed 10 drops 3 times a day.
The course of treatment is 2-4 weeks.
If necessary, the course of treatment can be repeated after 1 month following consultation with a doctor.
In cases requiring rapid relief of symptoms, it is possible to take the drug every 0.5-1 hour until improvement occurs (but not more than 8 times), after which it should be taken 3 times a day.
Take orally undiluted or after dilution in 1 tablespoon of water, 30 minutes before or 1 hour after a meal, holding it in the mouth for 20-30 seconds before swallowing.
Adverse Reactions
Rarely:increased salivation.
The patient should be informed that if other side effects occur, they should consult a doctor.
Contraindications
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The issue of using the drug Vocara® during pregnancy and lactation (breastfeeding) is decided by the doctor individually.
Pediatric Use
Data on use in children under 12 years of age are not available.
Adolescents over 12 years of age are prescribed 10 drops 3 times a day.
The course of treatment is 2-4 weeks.
If necessary, the course of treatment can be repeated after 1 month following consultation with a doctor.
Special Precautions
Since the drug Vocara® contains natural herbal components, slight cloudiness of the solution or weakening of the odor and taste may be observed during storage, which does not lead to a decrease in the effectiveness of the drug.
Overdose
Cases of overdose have not been reported to date.
Drug Interactions
Clinically significant interaction of the drug Vocara® with other drugs has not been established.
Storage Conditions
The drug should be stored at a temperature not exceeding 25°C (77°F) in a place protected from light and strong electromagnetic fields, out of the reach of children.
Shelf Life
Shelf life – 5 years. Do not use after the expiration date printed on the packaging.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Kagocel pills 12mg, 30pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Arbidol, capsules 100mg, 40pcs
Daivobet, ointment, 30g
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs 